Neutralising antibodies against interferon-β and their correlation with clinical and magnetic resonance imaging activity in Japanese multiple sclerosis patients

被引：0
|
作者：
Sato, D.
Nakashima, I.
Fukazawa, T.
Shimizu, Y.
Tomizawa, Y.
Yokoyama, K.
Misu, T.
Itoyama, Y.
Aoki, M.
Fujihara, K.
机构：
[1] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
[2] Sapporo Neurol Clin, Sapporo, Hokkaido, Japan
[3] Tokyo Womens Med Univ, Sch Med, Tokyo, Japan
[4] Juntendo Univ, Sch Med, Tokyo 113, Japan
[5] Natl Ctr Neurol & Psychiat, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：471 / 471
页数：1
相关论文
共 50 条
  • [31] NEUTRALISING ANTIBODIES TO INTERFERON-BETA PREDICT CONVERSION TO SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN PATIENTS WITH MULTIPLE SCLEROSIS
    Gafson, Arie
    Worthington, Viki
    Lakdawala, Neghat
    Giovannoni, Gavin
    Farrell, Rachel
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [32] How do patients with neutralising antibodies to recombinant interferon-β treatment develop in their clinical outcome?
    Fink, K.
    Westerlind, H.
    Lundkvist, M.
    Fogdell-Hahn, A.
    Hillert, J.
    JOURNAL OF NEUROLOGY, 2011, 258 : 264 - 264
  • [33] Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-β
    Hesse, D.
    Frederiksen, J. L.
    Koch-Henriksen, N.
    Schreiber, K.
    Stenager, E.
    Heltberg, A.
    Ravnborg, M.
    Bendtzen, K.
    Sellebjerg, F.
    Sorensen, P. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (01) : 43 - 47
  • [34] Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study)
    Magyari, Melinda
    Sondergaard, Helle Bach
    Sellebjerg, Finn
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (02) : 141 - 146
  • [35] Effect of interferonβ and the development of neutralising antibodies, on reactivation of latent EBV, in patients with multiple sclerosis
    Farrell, Rachel
    Antony, Dinu
    Clark, Duncan
    Garson, Jeremy
    Miller, David H.
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS, 2008, 14 : S229 - S229
  • [36] Neutralising antibodies to interferon beta in a population-based cohort of patients with multiple sclerosis
    Cossoy, M. B.
    Rush, C.
    Kremenchutzky, M.
    Bhan, V.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 : S61 - S61
  • [37] Neutralising antibodies in patients with multiple sclerosis treated with interferon beta-1b
    Río, J
    Barberà, N
    Tintoré, M
    Brieva, L
    Montalbán, X
    MEDICINA CLINICA, 2000, 114 (05): : 169 - 170
  • [38] Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis (vol 362, pg 1184, 2003)
    Sorensen, PS
    Ross, C
    Clemmensen, KM
    LANCET, 2004, 363 (9406): : 402 - 402
  • [39] Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
    Polman, Chris H.
    Bertolotto, Antonio
    Deisenhammer, Florian
    Giovannoni, Gavin
    Hartung, Hans-Peter
    Hemmer, Bernhard
    Killestein, Joep
    McFarland, Henry F.
    Oger, Joel
    Pachner, Andrew R.
    Petkau, John
    Reder, Anthony T.
    Reingold, Stephen C.
    Schellekens, Huub
    Sorensen, Per Soelberg
    LANCET NEUROLOGY, 2010, 9 (07): : 740 - 750
  • [40] Antibodies to interferon-β in multiple sclerosis patients:: Measurement by a commercially available kit
    Pachner, AR
    Rao, T
    Cook, S
    Jotkowitz, A
    Patalapati, R
    Quinless, J
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 477 - +
12345